Motivated each day by the opportunity to make a difference in the lives of patients, Christoph has extensive experience in leading Development teams and organizations in all stages of development from first in human to late stage development. As a physician, his compassion for patients drives his interest in innovation in clinical trials. Christoph understands that the greatest benefit of a successful launch will be patients’ access to a novel treatment. Christoph is equally passionate about interacting with regulatory authorities globally as well as ensuring safety and access for patients on a local level.

Christoph is currently heading up Bayers Global Development and Clinical Operations where he oversees the clinical development of the entire portfolio including executing clinical studies globally. He joined Bayer from Otsuka where, as Chief Medical Officer, he oversaw the entire development Organization including Clinical Pharmacology and translational Medicine, clinical development and operations, Drug Safety, Regulatory Affairs and Quality, Data Management and Analytics, Real world and Value evidence, Technical operations, Medical Affairs as well as portfolio and asset management.

Before joining Otsuka in 2019, Christoph was Head of Cardiovascular Medicine and Development at Bristol-Meyers Squibb (BMS), helping to develop its next generation of cardiovascular medicines. Prior to his role at BMS, Christoph worked for Novo Nordisk in various medical and development functions in Europe, as well as in the US. Christoph’s medical background has informed his ability to combine scientific innovation with a strategic approach to business development opportunities, regulatory navigation, and global patient access solutions.

Christoph received his medical degree from Ruprecht-Karls University School of Medicine in Heidelberg, Germany, in 1994. He also holds an MBA from Schiller International University, and is board certified in internal medicine and diabetology.